ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Prostate Cancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-1P7758
Home | Market Reports | Health| Men s Health
Global Prostate Cancer Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Prostate Cancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-1P7758
Report
September 2024
Pages:164
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Merck Group
Novartis
Amgen Inc
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals

Prostate Cancer Drugs - Market Size

The global market for Prostate Cancer Drugs was estimated to be worth US$ 6310.3 million in 2023 and is forecast to a readjusted size of US$ 10100 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030

Prostate Cancer Drugs - Market

Prostate Cancer Drugs - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Prostate Cancer Drugs by region & country, by Type, and by Application.
The Prostate Cancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Drugs.
Market Segmentation

Scope of Prostate Cancer Drugs - Market Report

Report Metric Details
Report Name Prostate Cancer Drugs - Market
Forecasted market size in 2030 US$ 10100 million
CAGR 6.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Hormonal Therapy
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
Segment by Application
  • Clinics
  • Hospitals
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis, Amgen, Bayer HealthCare, Ferring Pharmaceutical, Janssen Pharmaceuticals, Endo Pharmaceuticals, BMS, Takeda Pharmaceuticals, Northwest Biotherapeutics, Teva Pharmaceutical, Boehringer Ingelheim, Foresee Pharmaceuticals, Tokai Pharmaceuticals, Spectrum Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Prostate Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Prostate Cancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Prostate Cancer Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Prostate Cancer Drugs - Market size in 2030?

Ans: The Prostate Cancer Drugs - Market size in 2030 will be US$ 10100 million.

Who are the main players in the Prostate Cancer Drugs - Market report?

Ans: The main players in the Prostate Cancer Drugs - Market are AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis, Amgen, Bayer HealthCare, Ferring Pharmaceutical, Janssen Pharmaceuticals, Endo Pharmaceuticals, BMS, Takeda Pharmaceuticals, Northwest Biotherapeutics, Teva Pharmaceutical, Boehringer Ingelheim, Foresee Pharmaceuticals, Tokai Pharmaceuticals, Spectrum Pharmaceuticals

What are the Application segmentation covered in the Prostate Cancer Drugs - Market report?

Ans: The Applications covered in the Prostate Cancer Drugs - Market report are Clinics, Hospitals, Others

What are the Type segmentation covered in the Prostate Cancer Drugs - Market report?

Ans: The Types covered in the Prostate Cancer Drugs - Market report are Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy

1 Market Overview
1.1 Prostate Cancer Drugs Product Introduction
1.2 Global Prostate Cancer Drugs Market Size Forecast
1.2.1 Global Prostate Cancer Drugs Sales Value (2019-2030)
1.2.2 Global Prostate Cancer Drugs Sales Volume (2019-2030)
1.2.3 Global Prostate Cancer Drugs Sales Price (2019-2030)
1.3 Prostate Cancer Drugs Market Trends & Drivers
1.3.1 Prostate Cancer Drugs Industry Trends
1.3.2 Prostate Cancer Drugs Market Drivers & Opportunity
1.3.3 Prostate Cancer Drugs Market Challenges
1.3.4 Prostate Cancer Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prostate Cancer Drugs Players Revenue Ranking (2023)
2.2 Global Prostate Cancer Drugs Revenue by Company (2019-2024)
2.3 Global Prostate Cancer Drugs Players Sales Volume Ranking (2023)
2.4 Global Prostate Cancer Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Prostate Cancer Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Prostate Cancer Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Prostate Cancer Drugs
2.9 Prostate Cancer Drugs Market Competitive Analysis
2.9.1 Prostate Cancer Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Prostate Cancer Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hormonal Therapy
3.1.2 Chemotherapy
3.1.3 Immunotherapy
3.1.4 Targeted Therapy
3.2 Global Prostate Cancer Drugs Sales Value by Type
3.2.1 Global Prostate Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prostate Cancer Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Prostate Cancer Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Prostate Cancer Drugs Sales Volume by Type
3.3.1 Global Prostate Cancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Prostate Cancer Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Prostate Cancer Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Prostate Cancer Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospitals
4.1.3 Others
4.2 Global Prostate Cancer Drugs Sales Value by Application
4.2.1 Global Prostate Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prostate Cancer Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Prostate Cancer Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Prostate Cancer Drugs Sales Volume by Application
4.3.1 Global Prostate Cancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Prostate Cancer Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Prostate Cancer Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Prostate Cancer Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Prostate Cancer Drugs Sales Value by Region
5.1.1 Global Prostate Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prostate Cancer Drugs Sales Value by Region (2019-2024)
5.1.3 Global Prostate Cancer Drugs Sales Value by Region (2025-2030)
5.1.4 Global Prostate Cancer Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Prostate Cancer Drugs Sales Volume by Region
5.2.1 Global Prostate Cancer Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Prostate Cancer Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Prostate Cancer Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Prostate Cancer Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Prostate Cancer Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Prostate Cancer Drugs Sales Value, 2019-2030
5.4.2 North America Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Prostate Cancer Drugs Sales Value, 2019-2030
5.5.2 Europe Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Prostate Cancer Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Prostate Cancer Drugs Sales Value, 2019-2030
5.7.2 South America Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Prostate Cancer Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prostate Cancer Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prostate Cancer Drugs Sales Value
6.2.1 Key Countries/Regions Prostate Cancer Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Prostate Cancer Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Prostate Cancer Drugs Sales Value, 2019-2030
6.3.2 United States Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prostate Cancer Drugs Sales Value, 2019-2030
6.4.2 Europe Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prostate Cancer Drugs Sales Value, 2019-2030
6.5.2 China Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prostate Cancer Drugs Sales Value, 2019-2030
6.6.2 Japan Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prostate Cancer Drugs Sales Value, 2019-2030
6.7.2 South Korea Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prostate Cancer Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prostate Cancer Drugs Sales Value, 2019-2030
6.9.2 India Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prostate Cancer Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Introduction and Business Overview
7.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AbbVie Prostate Cancer Drugs Product Offerings
7.1.5 AbbVie Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Information
7.2.2 Astellas Pharma Introduction and Business Overview
7.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Astellas Pharma Prostate Cancer Drugs Product Offerings
7.2.5 Astellas Pharma Recent Development
7.3 Astra Zeneca
7.3.1 Astra Zeneca Company Information
7.3.2 Astra Zeneca Introduction and Business Overview
7.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Astra Zeneca Prostate Cancer Drugs Product Offerings
7.3.5 Astra Zeneca Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Introduction and Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Johnson & Johnson Prostate Cancer Drugs Product Offerings
7.4.5 Johnson & Johnson Recent Development
7.5 Sanofi
7.5.1 Sanofi Company Information
7.5.2 Sanofi Introduction and Business Overview
7.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi Prostate Cancer Drugs Product Offerings
7.5.5 Sanofi Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Information
7.6.2 GlaxoSmithKline Introduction and Business Overview
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Offerings
7.6.5 GlaxoSmithKline Recent Development
7.7 Merck Group
7.7.1 Merck Group Company Information
7.7.2 Merck Group Introduction and Business Overview
7.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck Group Prostate Cancer Drugs Product Offerings
7.7.5 Merck Group Recent Development
7.8 Novartis
7.8.1 Novartis Company Information
7.8.2 Novartis Introduction and Business Overview
7.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Novartis Prostate Cancer Drugs Product Offerings
7.8.5 Novartis Recent Development
7.9 Amgen
7.9.1 Amgen Company Information
7.9.2 Amgen Introduction and Business Overview
7.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Amgen Prostate Cancer Drugs Product Offerings
7.9.5 Amgen Recent Development
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Company Information
7.10.2 Bayer HealthCare Introduction and Business Overview
7.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bayer HealthCare Prostate Cancer Drugs Product Offerings
7.10.5 Bayer HealthCare Recent Development
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Company Information
7.11.2 Ferring Pharmaceutical Introduction and Business Overview
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Offerings
7.11.5 Ferring Pharmaceutical Recent Development
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Company Information
7.12.2 Janssen Pharmaceuticals Introduction and Business Overview
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Offerings
7.12.5 Janssen Pharmaceuticals Recent Development
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Company Information
7.13.2 Endo Pharmaceuticals Introduction and Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Offerings
7.13.5 Endo Pharmaceuticals Recent Development
7.14 BMS
7.14.1 BMS Company Information
7.14.2 BMS Introduction and Business Overview
7.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 BMS Prostate Cancer Drugs Product Offerings
7.14.5 BMS Recent Development
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Company Information
7.15.2 Takeda Pharmaceuticals Introduction and Business Overview
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Offerings
7.15.5 Takeda Pharmaceuticals Recent Development
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Company Information
7.16.2 Northwest Biotherapeutics Introduction and Business Overview
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Offerings
7.16.5 Northwest Biotherapeutics Recent Development
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Company Information
7.17.2 Teva Pharmaceutical Introduction and Business Overview
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Offerings
7.17.5 Teva Pharmaceutical Recent Development
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Company Information
7.18.2 Boehringer Ingelheim Introduction and Business Overview
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Offerings
7.18.5 Boehringer Ingelheim Recent Development
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Company Information
7.19.2 Foresee Pharmaceuticals Introduction and Business Overview
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Offerings
7.19.5 Foresee Pharmaceuticals Recent Development
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Company Information
7.20.2 Tokai Pharmaceuticals Introduction and Business Overview
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Offerings
7.20.5 Tokai Pharmaceuticals Recent Development
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Company Information
7.21.2 Spectrum Pharmaceuticals Introduction and Business Overview
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offerings
7.21.5 Spectrum Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Prostate Cancer Drugs Industrial Chain
8.2 Prostate Cancer Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prostate Cancer Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Prostate Cancer Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline PLC
Merck Group
Novartis
Amgen Inc
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
List of Tables
    Table 1. Prostate Cancer Drugs Market Trends
    Table 2. Prostate Cancer Drugs Market Drivers & Opportunity
    Table 3. Prostate Cancer Drugs Market Challenges
    Table 4. Prostate Cancer Drugs Market Restraints
    Table 5. Global Prostate Cancer Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Prostate Cancer Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Prostate Cancer Drugs Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Prostate Cancer Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Prostate Cancer Drugs Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Prostate Cancer Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Prostate Cancer Drugs
    Table 13. Global Prostate Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Prostate Cancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Prostate Cancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Prostate Cancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Prostate Cancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Prostate Cancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Prostate Cancer Drugs Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Prostate Cancer Drugs Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Prostate Cancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Prostate Cancer Drugs Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Prostate Cancer Drugs Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Prostate Cancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Prostate Cancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Prostate Cancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Prostate Cancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Prostate Cancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Prostate Cancer Drugs Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Prostate Cancer Drugs Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Prostate Cancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Prostate Cancer Drugs Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Prostate Cancer Drugs Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Prostate Cancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Prostate Cancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Prostate Cancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Prostate Cancer Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Prostate Cancer Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Prostate Cancer Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Prostate Cancer Drugs Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Prostate Cancer Drugs Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Prostate Cancer Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Prostate Cancer Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Prostate Cancer Drugs Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Prostate Cancer Drugs Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Prostate Cancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Prostate Cancer Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Prostate Cancer Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Prostate Cancer Drugs Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Prostate Cancer Drugs Sales Volume, (2025-2030) & (K MT)
    Table 57. AbbVie Company Information
    Table 58. AbbVie Introduction and Business Overview
    Table 59. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. AbbVie Prostate Cancer Drugs Product Offerings
    Table 61. AbbVie Recent Development
    Table 62. Astellas Pharma Company Information
    Table 63. Astellas Pharma Introduction and Business Overview
    Table 64. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Astellas Pharma Prostate Cancer Drugs Product Offerings
    Table 66. Astellas Pharma Recent Development
    Table 67. Astra Zeneca Company Information
    Table 68. Astra Zeneca Introduction and Business Overview
    Table 69. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Astra Zeneca Prostate Cancer Drugs Product Offerings
    Table 71. Astra Zeneca Recent Development
    Table 72. Johnson & Johnson Company Information
    Table 73. Johnson & Johnson Introduction and Business Overview
    Table 74. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Johnson & Johnson Prostate Cancer Drugs Product Offerings
    Table 76. Johnson & Johnson Recent Development
    Table 77. Sanofi Company Information
    Table 78. Sanofi Introduction and Business Overview
    Table 79. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Sanofi Prostate Cancer Drugs Product Offerings
    Table 81. Sanofi Recent Development
    Table 82. GlaxoSmithKline Company Information
    Table 83. GlaxoSmithKline Introduction and Business Overview
    Table 84. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. GlaxoSmithKline Prostate Cancer Drugs Product Offerings
    Table 86. GlaxoSmithKline Recent Development
    Table 87. Merck Group Company Information
    Table 88. Merck Group Introduction and Business Overview
    Table 89. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Merck Group Prostate Cancer Drugs Product Offerings
    Table 91. Merck Group Recent Development
    Table 92. Novartis Company Information
    Table 93. Novartis Introduction and Business Overview
    Table 94. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Novartis Prostate Cancer Drugs Product Offerings
    Table 96. Novartis Recent Development
    Table 97. Amgen Company Information
    Table 98. Amgen Introduction and Business Overview
    Table 99. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Amgen Prostate Cancer Drugs Product Offerings
    Table 101. Amgen Recent Development
    Table 102. Bayer HealthCare Company Information
    Table 103. Bayer HealthCare Introduction and Business Overview
    Table 104. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Bayer HealthCare Prostate Cancer Drugs Product Offerings
    Table 106. Bayer HealthCare Recent Development
    Table 107. Ferring Pharmaceutical Company Information
    Table 108. Ferring Pharmaceutical Introduction and Business Overview
    Table 109. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Ferring Pharmaceutical Prostate Cancer Drugs Product Offerings
    Table 111. Ferring Pharmaceutical Recent Development
    Table 112. Janssen Pharmaceuticals Company Information
    Table 113. Janssen Pharmaceuticals Introduction and Business Overview
    Table 114. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Janssen Pharmaceuticals Prostate Cancer Drugs Product Offerings
    Table 116. Janssen Pharmaceuticals Recent Development
    Table 117. Endo Pharmaceuticals Company Information
    Table 118. Endo Pharmaceuticals Introduction and Business Overview
    Table 119. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Endo Pharmaceuticals Prostate Cancer Drugs Product Offerings
    Table 121. Endo Pharmaceuticals Recent Development
    Table 122. BMS Company Information
    Table 123. BMS Introduction and Business Overview
    Table 124. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. BMS Prostate Cancer Drugs Product Offerings
    Table 126. BMS Recent Development
    Table 127. Takeda Pharmaceuticals Company Information
    Table 128. Takeda Pharmaceuticals Introduction and Business Overview
    Table 129. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Takeda Pharmaceuticals Prostate Cancer Drugs Product Offerings
    Table 131. Takeda Pharmaceuticals Recent Development
    Table 132. Northwest Biotherapeutics Company Information
    Table 133. Northwest Biotherapeutics Introduction and Business Overview
    Table 134. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 135. Northwest Biotherapeutics Prostate Cancer Drugs Product Offerings
    Table 136. Northwest Biotherapeutics Recent Development
    Table 137. Teva Pharmaceutical Company Information
    Table 138. Teva Pharmaceutical Introduction and Business Overview
    Table 139. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 140. Teva Pharmaceutical Prostate Cancer Drugs Product Offerings
    Table 141. Teva Pharmaceutical Recent Development
    Table 142. Boehringer Ingelheim Company Information
    Table 143. Boehringer Ingelheim Introduction and Business Overview
    Table 144. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 145. Boehringer Ingelheim Prostate Cancer Drugs Product Offerings
    Table 146. Boehringer Ingelheim Recent Development
    Table 147. Foresee Pharmaceuticals Company Information
    Table 148. Foresee Pharmaceuticals Introduction and Business Overview
    Table 149. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 150. Foresee Pharmaceuticals Prostate Cancer Drugs Product Offerings
    Table 151. Foresee Pharmaceuticals Recent Development
    Table 152. Tokai Pharmaceuticals Company Information
    Table 153. Tokai Pharmaceuticals Introduction and Business Overview
    Table 154. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 155. Tokai Pharmaceuticals Prostate Cancer Drugs Product Offerings
    Table 156. Tokai Pharmaceuticals Recent Development
    Table 157. Spectrum Pharmaceuticals Company Information
    Table 158. Spectrum Pharmaceuticals Introduction and Business Overview
    Table 159. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 160. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offerings
    Table 161. Spectrum Pharmaceuticals Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Prostate Cancer Drugs Downstream Customers
    Table 165. Prostate Cancer Drugs Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Prostate Cancer Drugs Product Picture
    Figure 2. Global Prostate Cancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Prostate Cancer Drugs Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Prostate Cancer Drugs Sales Price (2019-2030) & (USD/MT)
    Figure 6. Prostate Cancer Drugs Report Years Considered
    Figure 7. Global Prostate Cancer Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Prostate Cancer Drugs Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Cancer Drugs Revenue in 2023
    Figure 10. Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Hormonal Therapy Picture
    Figure 12. Chemotherapy Picture
    Figure 13. Immunotherapy Picture
    Figure 14. Targeted Therapy Picture
    Figure 15. Global Prostate Cancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Prostate Cancer Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Prostate Cancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 18. Global Prostate Cancer Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Prostate Cancer Drugs Price by Type (2019-2030) & (USD/MT)
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Hospitals
    Figure 22. Product Picture of Others
    Figure 23. Global Prostate Cancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Prostate Cancer Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Prostate Cancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 26. Global Prostate Cancer Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Prostate Cancer Drugs Price by Application (2019-2030) & (USD/MT)
    Figure 28. North America Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Prostate Cancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Prostate Cancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Prostate Cancer Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Prostate Cancer Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Prostate Cancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Prostate Cancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Prostate Cancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. Prostate Cancer Drugs Industrial Chain
    Figure 62. Prostate Cancer Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions